Articles dans des revues avec comité de lecture (179)
  1. 35. Avila, M., Dufour, J. F., Gerbes, A. L., Zoulim, F., Bataller, R., Burra, P., Cortez-Pinto, H., Gao, B., Gilmore, I., Mathurin, P., Moreno, C., Poznyak, V., Schnabl, B., Szabo, G., Thiele, M., & Thursz, M. M. (2019). Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting. Gut. doi:10.1136/gutjnl-2019-319720
  2. 36. Zeuzem, S., Bourgeois, S., Greenbloom, S., Buti, M., Aghemo, A., Lampertico, P., Janczewska, E., Lim, S. G., Moreno, C., Buggisch, P., Tam, E., Corbett, C., Willems, W., Vijgen, L., Fevery, B., Ouwerkerk-Mahadevan, S., Ackaert, O., Beumont, M., Kalmeijer, R., Sinha, R., & Biermer, M. (2019). JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1. Hepatology. doi:10.1002/hep.30527
  3. 37. Barrail-Tran, A., Goldwirt, L., Gelé, T., Laforest, C., Lavenu, A., Danjou, H., Radenne, S., Leroy, V., Houssel-Debry, P., Duvoux, C., Kamar, N., De Ledinghen, V., Canva, V., Conti, F., Durand, F., D’Alteroche, L., Botta-Fridlund, D., Moreno, C., Cagnot, C., Samuel, D., Fougerou-Leurent, C., Pageaux, G.-P., Duclos-Vallée, J.-C., Taburet, A. M., & Coilly, A. (2019). Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort. European Journal of Clinical Pharmacology. doi:10.1007/s00228-019-02725-x
  4. 38. Van Hees, S., Chi, H., Hansen, B., Bourgeois, S., Van Vlierberghe, H., Serste, T., Francque, S., Wong, D., Sprengers, D., Moreno, C., Nevens, F., Janssen, H. H., & Vanwolleghem, T. (2019). Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced HBeAg seroconversion. Journal of viral hepatitis. doi:10.1111/jvh.13084
  5. 39. Hedskog, C., Parhy, B., Chang, S., Zeuzem, S., Moreno, C., Shafran, S. S., Borgia, S. S., Asselah, T., Alric, L., Abergel, A., Chen, J. J., Collier, J., Kapoor, D., Hyland, R. R., Simmonds, P., Mo, H., & Svarovskaia, E. (2019). Identification of 19 novel hepatitis C virus subtypes-further expanding HCV classification. Open Forum Infectious Diseases, 6(3), ofz076. doi:10.1093/ofid/ofz076
  6. 40. Asselah, T., Alami, N. N., Moreno, C., Pol, S., Karatapanis, S., Gschwantler, M., Horsmans, Y., Elefsiniotis, I., Larrey, D., Ferrari, C., Rizzetto, M., Orlandini, A., Calleja, J. L. U. J., Bruno, S., Schnell, G., Qaqish, R. R., Redman, R., Pilot-Matias, T., Kopecky-Bromberg, S., Yu, Y., & Mobashery, N. (2019). Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II). Health Science Reports, 2(3), e92. doi:10.1002/hsr2.92
  7. 41. Moreno, C., Mueller, S., & Szabo, G. (2019). Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Journal of hepatology, 70(2), 273-283. doi:10.1016/j.jhep.2018.11.025
  8. 42. Bataller, R., Arteel, G. G., Moreno, C., & Shah, V. H. (2019). Alcohol-related liver disease: Time for action. Journal of hepatology, 70(2), 221-222. doi:10.1016/j.jhep.2018.12.007
  9. 43. Clària, J., Moreau, R., Fenaille, F., Amoros, A., Junot, C., Gronbaek, H., Coenraad, M. J., Pruvost, A., Ghettas, A., Chu-Van, E., López-Vicario, C., Oettl, K., Caraceni, P., Alessandria, C., Trebicka, J., Pavesi, M., Deulofeu, C., Albillos, A., Gustot, T., Welzel, T. M., Fernandez, J., Stauber, R., Saliba, F., Butin, N., Colsch, B., Moreno, C., Durand, F., Nevens, F., Bañares, R., Benten, D., Gines, P., Gerbes, A. L., Jalan, R., Angeli, P., Bernardi, M., Arroyo, V., & CANONIC Study Investigators of the EASL Clif Consortium, G. C. A. T. E. F. F. T. S. O. C. L. F. (. C. (2019). Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis. Hepatology, 69(4), 1686-1701. doi:10.1002/hep.30363
  10. 44. Ganne-Carrié, N., Chaffaut, C., Bourcier, V., Archambeaud, I., Perarnau, J. M., Oberti, F., Roulot, D., Moreno, C., Louvet, A., Dao, T., Moirand, R., Goria, O., Nguyen-Khac, E., Carbonell, N., Antonini, T. M., Pol, S., De Ledinghen, V., Ozenne, V., Henrion, J., Péron, J. M., Tran, A., Perlemuter, G., Amiot, X., Zarski, J.-P., Beaugrand, M., & Chevret, S. (2018). Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis. Journal of hepatology, 69(6), 1274-1283. doi:10.1016/j.jhep.2018.07.022
  11. 45. Houssel-Debry, P., Coilly, A., Fougerou-Leurent, C., Jezequel, C., Duvoux, C., De Ledinghen, V., Radenne, S., Kamar, N., Leroy, V., Martino, V. D., D'Alteroche, L., Canva, V., Conti, F., Dumortier, J., Montialoux, H., Lebray, P., Botta-Fridlund, D., Tran, A., Moreno, C., Silvain, C., Besch, C., Perre, P., Francoz, C., Abergel, A., Habersetzer, F., Debette-Gratien, M., Cagnot, C., Diallo, A., Chevaliez, S., Rossignol, E., Veislinger, A., Duclos-Vallée, J.-C., & Pageaux, G.-P. (2018). 12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation. Hepatology, 68(4), 1277-1287. doi:10.1002/hep.29918
  12. 46. Nguyen-Khac, E., Thiele, M., Voican, C., Nahon, P., Moreno, C., Boursier, J., Mueller, S., De Ledinghen, V., Starkel, P., Gyune Kim, S., Fernandez Y Viesca, M., Madsen, B., Naveau, S., Krag, A., Perlemuter, G., Ziol, M., Chatelain, D., & Diouf, M. (2018). Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. The Lancet Gastroenterology and Hepatology, 3(9), 614-625. doi:10.1016/S2468-1253(18)30124-9
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>